《美股業績》安進藥廠(AMGN.US)季績勝預期 料下月披露研發肥胖治療藥數據
美國生物科技公司安進藥廠(AMGN.US)公布第三季業績。季度純利21.43億美元,按年升14%。每股季度攤薄純利3.98美元,經調整後為4.7美元,高於市場預期的4.42美元,季度派息每股1.94美元。季度收入按年跌1%至66.52億美元,高於市場預期的65.6億美元。
公司預期現年度經調整每股盈利介乎17.25至17.65美元,中位數17.45美元。早前預測為介乎17至18美元,中位數17.5美元。公司亦預期現年度收入介乎260億至263億美元,中位數261.5億美元,早前預測為介乎255億至264億美元,中位數259.5億美元。
公司表示,將於下月一場國際會議上披露研發肥胖治療藥AMG133的首階段研究數據。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.